切勿混用!AFX内移植物搭配不同近端主动脉袖套的长期结局
这项回顾性单中心研究纳入134例接受AFX一体式内移植物联合肾上主动脉袖套(Endologix组86例、Medtronic组48例)的腹主动脉瘤患者,中位随访41个月。混合器械组3A型内漏发生率12.8%,显著高于全Endologix组(P<0.001);Endurant袖套与3A型内漏风险(HR 16.5)和再干预风险(HR 9.67)显著增加相关。
要点
- AFX联合Medtronic袖套的混合器械组3A型内漏发生率12.8%,显著高于全Endologix组(P<0.001)。
- 使用Endurant袖套与3A型内漏风险显著增加相关(HR 16.5;95%CI 1.9-143;P=0.011)。
- 使用Endurant袖套与再干预风险显著增加相关(HR 9.67;95%CI 1.9-49.6;P=0.006)。
核心结论
- 混合使用不同制造商的移植物,尤其是材料和密封机制不同者,可能损害某些EVAR修复的长期完整性。
- 临床医生在考虑混合器械配置时应谨慎,并确保对此类植入患者进行严格随访。
研究设计与样本
- 回顾性单中心研究,纳入2011年11月至2022年11月间134例连续AAA患者,均使用AFX一体式内移植物联合肾上主动脉袖套行EVAR。
主要发现
- 中位随访41个月,6例(4.5%)发生3A型内漏,平均发生于34.8个月;混合器械组为12.8%,显著更高(P<0.001)。
- 3A型内漏与重叠无关,并随时间推移而出现。
- 任何类型内漏发生于17例患者,12例患者需要再干预。
- 使用Endurant袖套与3A型内漏风险显著增加相关(HR 16.5;95%CI 1.9-143;P=0.011),与再干预风险显著增加相关(HR 9.67;95%CI 1.9-49.6;P=0.006)。
临床怎么用
- 作者认为,临床医生在考虑混合器械配置时应谨慎,并确保对此类植入患者进行严格随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff. This study aims to evaluate the long-term outcomes of patients treated with an all-Endologix implant versus a combination of Endologix and Medtronic devices. METHODS: This retrospective, single-center study included 134 consecutive AAA patients who underwent endovascular aneurysm repair (EVAR) using the AFX unibody endograft paired with suprarenal aortic cuffs from Endologix (n = 86) or Medtronic (n = 48) between November 2011 and November 2022. Patients were divided into 2 groups based on the type of aortic cuff used. The primary outcome was the occurrence of type 3A endoleaks at the longest available follow-up. Secondary outcomes included any endoleak, reintervention rates, all-cause mortality, and aneurysm-related death. RESULTS: The median follow-up was 41 months, and type 3A endoleaks occurred after a mean 34.8 months in 6 patients (4.5%), which is significantly more frequent in the mixed-device group (12.8%) (P < 0.001). Type 3A endoleak occurred regardless of overlap and developed over time. Endoleaks of any type were reported in 17 patients. Reinterventions were needed in 12 patients. The use of an Endurant cuff was associated with a significantly increased risk of type 3A endoleaks (hazard ratio [HR] 16.5; 95% [CI] 1.9-143; P = 0.011) and reinterventions (HR 9.67; 95% CI 1.9-49.6; P = 0.006). CONCLUSIONS: Combining endografts from different manufacturers, especially those with differing materials and sealing mechanisms, may compromise the long-term integrity of certain EVAR repairs. Clinicians should exercise caution when considering mixed-device configurations and ensure rigorous follow-up for patients with such implants.
引用
- Accarino G, Puca AE, Rinaldi A, et al. Do Not Mix It up! Long-Term Outcomes of Different Proximal Aortic Cuffs with the AFX Endograft. Ann Vasc Surg. 2024. PMID: 39581314. doi:10.1016/j.avsg.2024.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。